Aim 1

Determine the effect of higher versus standard dose influenza vaccine on AKI

X-axis is the relative Risk Reduction for High Dose Vaccine (\(1 - p_H / p_S\)). Each curve assumes a proportion of AKI hospitalization over All hospitalization. Therefore, total AKI hospitalization will be calculated by 1296 (composite events for main trial) TIMES 0.7 (70% hospitalization, 30% death) TIMES AKI hosp rate (each curve) DIVIDED BY 9300 (total number of subjects in the main trial) * 8800 (total number of subjects in our trial). Power is calculated by comparing two proportions.

Aim 2

Determine the effect of higher versus standard dose influenza vaccine on death/cardiopulmonary hospitalizations in patients with CKD

X-axis is the relative Risk Reduction for High Dose Vaccine (\(1 - p_H / p_S\)). Each curve assumes a proportion of CKD population in the whole cohort. Power is calculated by comparing two proportions.

Aim 3

I combined session 3.1 and 3.2 because both of them are comparing High versus Standard with an binary outcome. Each curve represent proportion of “present” in the standard dose, and X-axis is the relative Risk Reduction for High Dose Vaccine (\(1 - p_H / p_S\)). Power is calculated by comparing two proportions.